This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.
This archival content was originally written for and published on KPCC.org. Keep in mind that links and images may no longer work — and references may be outdated.
Calif. stem cell agency approves 5-year strategic plan
Close up of an injection of embryonic stem cells in a mouse to set a genetically modified line.
(
ANNE-CHRISTINE POUJOULAT/AFP/Getty Images
)
Listen
0:46
Calif. stem cell agency approves 5-year strategic plan
The governing board of California's stem cell agency Thursday approved a five-year strategic plan that commits it to a rapid escalation of its development of potential stem cell therapies.
The board of the California Institute for Regenerative Medicine unanimously approved the plan at a meeting in Los Angeles. The strategy calls for funding 50 new clinical trials by 2020 - a sharp increase over the 15 the Institute has funded since its founding a decade ago.
The board signed on to hiring experts skilled at moving stem cell research into human trials and to working with the U.S. Food and Drug Administration to ease regulatory rules that the agency considers burdensome, according to Institute President C. Randall Mills.
As part of its new strategy, the agency will offer a $75 million grant to a private firm willing to invest $75 million of its own money to create a stem cell company jointly run with the Institute. Mills says that investor would then have its pick of some of the Institute's most promising research.
The Institute was launched in 2005, after California voters approved a $3 billion bond measure to create it.
We have more details on this story here.
You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief
